Publication | Closed Access
A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
196
Citations
17
References
2012
Year
InflammationMetabolic SyndromeDiabetes ManagementAutoimmune DiseaseMedicineDiabetesImmunologyType 2Anti-inflammatory EffectsDiabetes MellitusDipeptidyl Peptidase-4 InhibitorPharmacologyAtherosclerosis
| Year | Citations | |
|---|---|---|
Page 1
Page 1